 | • レポートコード：QAF27651 • 出版社/出版日：QYResearch / 2021年4月16日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、134ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のDNAワクチン市場について種類別（組換えタンパク質ワクチン、遺伝子ベースのワクチン）、用途別（人間用、動物用）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・DNAワクチン市場の概要 ・世界の主要地域別DNAワクチン市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のDNAワクチン市場規模2016-2021：種類別（組換えタンパク質ワクチン、遺伝子ベースのワクチン） ・世界のDNAワクチン市場予測2012-2027：種類別（組換えタンパク質ワクチン、遺伝子ベースのワクチン） ・世界のDNAワクチン市場規模2016-2021：用途別（人間用、動物用） ・世界のDNAワクチン市場予測2012-2027：用途別（人間用、動物用） ・DNAワクチンのアメリカ市場規模と予測2016-2021 ・DNAワクチンのヨーロッパ市場規模と予測2016-2021 ・DNAワクチンの中国市場規模と予測2016-2021 ・DNAワクチンの日本市場規模と予測2016-2021 ・DNAワクチンの東南アジア市場規模と予測2016-2021 ・DNAワクチンのインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Merck、GSK、Sanofi、Zoties、Elanco、Boehringer-Ingelheim、Indian Immunologicals、Plumbline Life Sciences） ・DNAワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・DNAワクチンの市場動向・機会・課題 ・調査の結論 |
The DNA vaccine in this report refers to the vaccines manufactured using recombinant DNA technology. The advent of these vaccines has revolutionized the healthcare market. These vaccines are more effective, as well as have less side-effects associated with them as compared to traditional vaccines.
North America is the largest consumption place, with a revenue market share nearly 58% in 2017. Following North America, Europe is the second largest consumption place with the revenue market share of 28% in 2017. Asia-Pacific is also an important sales area, especially in China.
Market Analysis and Insights: Global DNA Vaccines Market
The global DNA Vaccines market was valued at US$ 5030.2 in 2020 and will reach US$ 7850.3 million by the end of 2027, growing at a CAGR of 7.7% during 2022-2027.
Global DNA Vaccines Scope and Market Size
The global DNA Vaccines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global DNA Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Recombinant Protein Vaccine
Gene-Based Vaccine
Segment by Application
Human
Animal
The DNA Vaccines market is analysed and market size information is provided by regions (countries). Segment by Application, the DNA Vaccines market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Merck
GSK
Sanofi
Zoties
Elanco
Boehringer-Ingelheim
Indian Immunologicals
Plumbline Life Sciences
1 DNA Vaccines Market Overview
1.1 DNA Vaccines Product Scope
1.2 DNA Vaccines Segment by Type
1.2.1 Global DNA Vaccines Sales by Type (2016 & 2021 & 2027)
1.2.2 Recombinant Protein Vaccine
1.2.3 Gene-Based Vaccine
1.3 DNA Vaccines Segment by Application
1.3.1 Global DNA Vaccines Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Human
1.3.3 Animal
1.4 DNA Vaccines Market Estimates and Forecasts (2016-2027)
1.4.1 Global DNA Vaccines Market Size in Value Growth Rate (2016-2027)
1.4.2 Global DNA Vaccines Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global DNA Vaccines Price Trends (2016-2027)
2 DNA Vaccines Estimates and Forecasts by Region
2.1 Global DNA Vaccines Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global DNA Vaccines Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global DNA Vaccines Sales Market Share by Region (2016-2021)
2.2.2 Global DNA Vaccines Revenue Market Share by Region (2016-2021)
2.3 Global DNA Vaccines Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global DNA Vaccines Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global DNA Vaccines Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America DNA Vaccines Estimates and Projections (2016-2027)
2.4.2 Europe DNA Vaccines Estimates and Projections (2016-2027)
2.4.3 China DNA Vaccines Estimates and Projections (2016-2027)
2.4.4 Japan DNA Vaccines Estimates and Projections (2016-2027)
2.4.5 Southeast Asia DNA Vaccines Estimates and Projections (2016-2027)
2.4.6 India DNA Vaccines Estimates and Projections (2016-2027)
3 Global DNA Vaccines Competition Landscape by Players
3.1 Global Top DNA Vaccines Players by Sales (2016-2021)
3.2 Global Top DNA Vaccines Players by Revenue (2016-2021)
3.3 Global DNA Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in DNA Vaccines as of 2020)
3.4 Global DNA Vaccines Average Price by Company (2016-2021)
3.5 Manufacturers DNA Vaccines Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global DNA Vaccines Market Size by Type
4.1 Global DNA Vaccines Historic Market Review by Type (2016-2021)
4.1.1 Global DNA Vaccines Sales Market Share by Type (2016-2021)
4.1.2 Global DNA Vaccines Revenue Market Share by Type (2016-2021)
4.1.3 Global DNA Vaccines Price by Type (2016-2021)
4.2 Global DNA Vaccines Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global DNA Vaccines Sales Forecast by Type (2022-2027)
4.2.2 Global DNA Vaccines Revenue Forecast by Type (2022-2027)
4.2.3 Global DNA Vaccines Price Forecast by Type (2022-2027)
5 Global DNA Vaccines Market Size by Application
5.1 Global DNA Vaccines Historic Market Review by Application (2016-2021)
5.1.1 Global DNA Vaccines Sales Market Share by Application (2016-2021)
5.1.2 Global DNA Vaccines Revenue Market Share by Application (2016-2021)
5.1.3 Global DNA Vaccines Price by Application (2016-2021)
5.2 Global DNA Vaccines Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global DNA Vaccines Sales Forecast by Application (2022-2027)
5.2.2 Global DNA Vaccines Revenue Forecast by Application (2022-2027)
5.2.3 Global DNA Vaccines Price Forecast by Application (2022-2027)
6 North America DNA Vaccines Market Facts & Figures
6.1 North America DNA Vaccines Sales by Company
6.1.1 North America DNA Vaccines Sales by Company (2016-2021)
6.1.2 North America DNA Vaccines Revenue by Company (2016-2021)
6.2 North America DNA Vaccines Sales Breakdown by Type
6.2.1 North America DNA Vaccines Sales Breakdown by Type (2016-2021)
6.2.2 North America DNA Vaccines Sales Breakdown by Type (2022-2027)
6.3 North America DNA Vaccines Sales Breakdown by Application
6.3.1 North America DNA Vaccines Sales Breakdown by Application (2016-2021)
6.3.2 North America DNA Vaccines Sales Breakdown by Application (2022-2027)
7 Europe DNA Vaccines Market Facts & Figures
7.1 Europe DNA Vaccines Sales by Company
7.1.1 Europe DNA Vaccines Sales by Company (2016-2021)
7.1.2 Europe DNA Vaccines Revenue by Company (2016-2021)
7.2 Europe DNA Vaccines Sales Breakdown by Type
7.2.1 Europe DNA Vaccines Sales Breakdown by Type (2016-2021)
7.2.2 Europe DNA Vaccines Sales Breakdown by Type (2022-2027)
7.3 Europe DNA Vaccines Sales Breakdown by Application
7.3.1 Europe 134 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 134 Sales Breakdown by Application (2022-2027)
8 China DNA Vaccines Market Facts & Figures
8.1 China DNA Vaccines Sales by Company
8.1.1 China DNA Vaccines Sales by Company (2016-2021)
8.1.2 China DNA Vaccines Revenue by Company (2016-2021)
8.2 China DNA Vaccines Sales Breakdown by Type
8.2.1 China DNA Vaccines Sales Breakdown by Type (2016-2021)
8.2.2 China DNA Vaccines Sales Breakdown by Type (2022-2027)
8.3 China DNA Vaccines Sales Breakdown by Application
8.3.1 China 243 Sales Breakdown by Application (2016-2021)
8.3.2 China 243 Sales Breakdown by Application (2022-2027)
9 Japan DNA Vaccines Market Facts & Figures
9.1 Japan DNA Vaccines Sales by Company
9.1.1 Japan DNA Vaccines Sales by Company (2016-2021)
9.1.2 Japan DNA Vaccines Revenue by Company (2016-2021)
9.2 Japan DNA Vaccines Sales Breakdown by Type
9.2.1 Japan DNA Vaccines Sales Breakdown by Type (2016-2021)
9.2.2 Japan DNA Vaccines Sales Breakdown by Type (2022-2027)
9.3 Japan DNA Vaccines Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia DNA Vaccines Market Facts & Figures
10.1 Southeast Asia DNA Vaccines Sales by Company
10.1.1 Southeast Asia DNA Vaccines Sales by Company (2016-2021)
10.1.2 Southeast Asia DNA Vaccines Revenue by Company (2016-2021)
10.2 Southeast Asia DNA Vaccines Sales Breakdown by Type
10.2.1 Southeast Asia DNA Vaccines Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia DNA Vaccines Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia DNA Vaccines Sales Breakdown by Application
10.3.1 Southeast Asia K Doses Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Doses Sales Breakdown by Application (2022-2027)
11 India DNA Vaccines Market Facts & Figures
11.1 India DNA Vaccines Sales by Company
11.1.1 India DNA Vaccines Sales by Company (2016-2021)
11.1.2 India DNA Vaccines Revenue by Company (2016-2021)
11.2 India DNA Vaccines Sales Breakdown by Type
11.2.1 India DNA Vaccines Sales Breakdown by Type (2016-2021)
11.2.2 India DNA Vaccines Sales Breakdown by Type (2022-2027)
11.3 India DNA Vaccines Sales Breakdown by Application
11.3.1 India DNA Vaccines Sales Breakdown by Application (2016-2021)
11.3.2 India DNA Vaccines Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in DNA Vaccines Business
12.1 Merck
12.1.1 Merck Corporation Information
12.1.2 Merck Business Overview
12.1.3 Merck DNA Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Merck DNA Vaccines Products Offered
12.1.5 Merck Recent Development
12.2 GSK
12.2.1 GSK Corporation Information
12.2.2 GSK Business Overview
12.2.3 GSK DNA Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.2.4 GSK DNA Vaccines Products Offered
12.2.5 GSK Recent Development
12.3 Sanofi
12.3.1 Sanofi Corporation Information
12.3.2 Sanofi Business Overview
12.3.3 Sanofi DNA Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Sanofi DNA Vaccines Products Offered
12.3.5 Sanofi Recent Development
12.4 Zoties
12.4.1 Zoties Corporation Information
12.4.2 Zoties Business Overview
12.4.3 Zoties DNA Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Zoties DNA Vaccines Products Offered
12.4.5 Zoties Recent Development
12.5 Elanco
12.5.1 Elanco Corporation Information
12.5.2 Elanco Business Overview
12.5.3 Elanco DNA Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Elanco DNA Vaccines Products Offered
12.5.5 Elanco Recent Development
12.6 Boehringer-Ingelheim
12.6.1 Boehringer-Ingelheim Corporation Information
12.6.2 Boehringer-Ingelheim Business Overview
12.6.3 Boehringer-Ingelheim DNA Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Boehringer-Ingelheim DNA Vaccines Products Offered
12.6.5 Boehringer-Ingelheim Recent Development
12.7 Indian Immunologicals
12.7.1 Indian Immunologicals Corporation Information
12.7.2 Indian Immunologicals Business Overview
12.7.3 Indian Immunologicals DNA Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Indian Immunologicals DNA Vaccines Products Offered
12.7.5 Indian Immunologicals Recent Development
12.8 Plumbline Life Sciences
12.8.1 Plumbline Life Sciences Corporation Information
12.8.2 Plumbline Life Sciences Business Overview
12.8.3 Plumbline Life Sciences DNA Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Plumbline Life Sciences DNA Vaccines Products Offered
12.8.5 Plumbline Life Sciences Recent Development
13 DNA Vaccines Manufacturing Cost Analysis
13.1 DNA Vaccines Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of DNA Vaccines
13.4 DNA Vaccines Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 DNA Vaccines Distributors List
14.3 DNA Vaccines Customers
15 Market Dynamics
15.1 DNA Vaccines Market Trends
15.2 DNA Vaccines Drivers
15.3 DNA Vaccines Market Challenges
15.4 DNA Vaccines Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global DNA Vaccines Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global DNA Vaccines Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global DNA Vaccines Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global DNA Vaccines Sales (K Doses) by Region (2016-2021)
Table 5. Global DNA Vaccines Sales Market Share by Region (2016-2021)
Table 6. Global DNA Vaccines Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global DNA Vaccines Revenue Share by Region (2016-2021)
Table 8. Global DNA Vaccines Sales (K Doses) Forecast by Region (2022-2027)
Table 9. Global DNA Vaccines Sales Market Share Forecast by Region (2022-2027)
Table 10. Global DNA Vaccines Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global DNA Vaccines Revenue Share Forecast by Region (2022-2027)
Table 12. Global DNA Vaccines Sales (K Doses) of Key Companies (2016-2021)
Table 13. Global DNA Vaccines Sales Share by Company (2016-2021)
Table 14. Global DNA Vaccines Revenue (US$ Million) by Company (2016-2021)
Table 15. Global DNA Vaccines Revenue Share by Company (2016-2021)
Table 16. Global DNA Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in DNA Vaccines as of 2020)
Table 17. Global DNA Vaccines Average Price (USD/Dose) of Key Company (2016-2021)
Table 18. Manufacturers DNA Vaccines Manufacturing Sites and Area Served
Table 19. Manufacturers DNA Vaccines Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global DNA Vaccines Sales (K Doses) by Type (2016-2021)
Table 22. Global DNA Vaccines Sales Share by Type (2016-2021)
Table 23. Global DNA Vaccines Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global DNA Vaccines Price (USD/Dose) by Type (2016-2021)
Table 25. Global DNA Vaccines Sales Share by Type (2022-2027)
Table 26. Global DNA Vaccines Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global DNA Vaccines Revenue Share by Type (2022-2027)
Table 28. Global DNA Vaccines Price (USD/Dose) by Type (2022-2027)
Table 29. Global DNA Vaccines Sales (K Doses) by Application (2016-2021)
Table 30. Global DNA Vaccines Sales Share by Application (2016-2021)
Table 31. Global DNA Vaccines Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global DNA Vaccines Price (USD/Dose) by Application (2016-2021)
Table 33. Global DNA Vaccines Sales (K Doses) by Application (2022-2027)
Table 34. Global DNA Vaccines Sales Share by Application (2022-2027)
Table 35. Global DNA Vaccines Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global DNA Vaccines Revenue Share by Application (2022-2027)
Table 37. Global DNA Vaccines Price (USD/Dose) by Application (2022-2027)
Table 38. North America DNA Vaccines Sales (K Doses) by Company (2016-2021)
Table 39. North America DNA Vaccines Sales Market Share by Company (2016-2021)
Table 40. North America DNA Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America DNA Vaccines Revenue Market Share by Company (2016-2021)
Table 42. North America DNA Vaccines Sales by Type (2016-2021) & (K Doses)
Table 43. North America DNA Vaccines Sales Market Share by Type (2016-2021)
Table 44. North America DNA Vaccines Sales by Type (2022-2027) & (K Doses)
Table 45. North America DNA Vaccines Sales Market Share by Type (2022-2027)
Table 46. North America DNA Vaccines Sales by Application (2016-2021) & (K Doses)
Table 47. North America DNA Vaccines Sales Market Share by Application (2016-2021)
Table 48. North America DNA Vaccines Sales by Application (2022-2027) & (K Doses)
Table 49. North America DNA Vaccines Sales Market Share by Application (2022-2027)
Table 50. Europe DNA Vaccines Sales (K Doses) by Company (2016-2021)
Table 51. Europe DNA Vaccines Sales Market Share by Company (2016-2021)
Table 52. Europe DNA Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe DNA Vaccines Revenue Market Share by Company (2016-2021)
Table 54. Europe DNA Vaccines Sales by Type (2016-2021) & (K Doses)
Table 55. Europe DNA Vaccines Sales Market Share by Type (2016-2021)
Table 56. Europe DNA Vaccines Sales by Type (2022-2027) & (K Doses)
Table 57. Europe DNA Vaccines Sales Market Share by Type (2022-2027)
Table 58. Europe DNA Vaccines Sales by Application (2016-2021) & (K Doses)
Table 59. Europe DNA Vaccines Sales Market Share by Application (2016-2021)
Table 60. Europe DNA Vaccines Sales by Application (2022-2027) & (K Doses)
Table 61. Europe DNA Vaccines Sales Market Share by Application (2022-2027)
Table 62. China DNA Vaccines Sales (K Doses) by Company (2016-2021)
Table 63. China DNA Vaccines Sales Market Share by Company (2016-2021)
Table 64. China DNA Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 65. China DNA Vaccines Revenue Market Share by Company (2016-2021)
Table 66. China DNA Vaccines Sales by Type (2016-2021) & (K Doses)
Table 67. China DNA Vaccines Sales Market Share by Type (2016-2021)
Table 68. China DNA Vaccines Sales by Type (2022-2027) & (K Doses)
Table 69. China DNA Vaccines Sales Market Share by Type (2022-2027)
Table 70. China DNA Vaccines Sales by Application (2016-2021) & (K Doses)
Table 71. China DNA Vaccines Sales Market Share by Application (2016-2021)
Table 72. China DNA Vaccines Sales by Application (2022-2027) & (K Doses)
Table 73. China DNA Vaccines Sales Market Share by Application (2022-2027)
Table 74. Japan DNA Vaccines Sales (K Doses) by Company (2016-2021)
Table 75. Japan DNA Vaccines Sales Market Share by Company (2016-2021)
Table 76. Japan DNA Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan DNA Vaccines Revenue Market Share by Company (2016-2021)
Table 78. Japan DNA Vaccines Sales by Type (2016-2021) & (K Doses)
Table 79. Japan DNA Vaccines Sales Market Share by Type (2016-2021)
Table 80. Japan DNA Vaccines Sales by Type (2022-2027) & (K Doses)
Table 81. Japan DNA Vaccines Sales Market Share by Type (2022-2027)
Table 82. Japan DNA Vaccines Sales by Application (2016-2021) & (K Doses)
Table 83. Japan DNA Vaccines Sales Market Share by Application (2016-2021)
Table 84. Japan DNA Vaccines Sales by Application (2022-2027) & (K Doses)
Table 85. Japan DNA Vaccines Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia DNA Vaccines Sales (K Doses) by Company (2016-2021)
Table 87. Southeast Asia DNA Vaccines Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia DNA Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia DNA Vaccines Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia DNA Vaccines Sales by Type (2016-2021) & (K Doses)
Table 91. Southeast Asia DNA Vaccines Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia DNA Vaccines Sales by Type (2022-2027) & (K Doses)
Table 93. Southeast Asia DNA Vaccines Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia DNA Vaccines Sales by Application (2016-2021) & (K Doses)
Table 95. Southeast Asia DNA Vaccines Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia DNA Vaccines Sales by Application (2022-2027) & (K Doses)
Table 97. Southeast Asia DNA Vaccines Sales Market Share by Application (2022-2027)
Table 98. India DNA Vaccines Sales (K Doses) by Company (2016-2021)
Table 99. India DNA Vaccines Sales Market Share by Company (2016-2021)
Table 100. India DNA Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 101. India DNA Vaccines Revenue Market Share by Company (2016-2021)
Table 102. India DNA Vaccines Sales by Type (2016-2021) & (K Doses)
Table 103. India DNA Vaccines Sales Market Share by Type (2016-2021)
Table 104. India DNA Vaccines Sales by Type (2022-2027) & (K Doses)
Table 105. India DNA Vaccines Sales Market Share by Type (2022-2027)
Table 106. India DNA Vaccines Sales by Application (2016-2021) & (K Doses)
Table 107. India DNA Vaccines Sales Market Share by Application (2016-2021)
Table 108. India DNA Vaccines Sales by Application (2022-2027) & (K Doses)
Table 109. India DNA Vaccines Sales Market Share by Application (2022-2027)
Table 110. Merck Corporation Information
Table 111. Merck Description and Business Overview
Table 112. Merck DNA Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 113. Merck DNA Vaccines Product
Table 114. Merck Recent Development
Table 115. GSK Corporation Information
Table 116. GSK Description and Business Overview
Table 117. GSK DNA Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 118. GSK DNA Vaccines Product
Table 119. GSK Recent Development
Table 120. Sanofi Corporation Information
Table 121. Sanofi Description and Business Overview
Table 122. Sanofi DNA Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 123. Sanofi DNA Vaccines Product
Table 124. Sanofi Recent Development
Table 125. Zoties Corporation Information
Table 126. Zoties Description and Business Overview
Table 127. Zoties DNA Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 128. Zoties DNA Vaccines Product
Table 129. Zoties Recent Development
Table 130. Elanco Corporation Information
Table 131. Elanco Description and Business Overview
Table 132. Elanco DNA Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 133. Elanco DNA Vaccines Product
Table 134. Elanco Recent Development
Table 135. Boehringer-Ingelheim Corporation Information
Table 136. Boehringer-Ingelheim Description and Business Overview
Table 137. Boehringer-Ingelheim DNA Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 138. Boehringer-Ingelheim DNA Vaccines Product
Table 139. Boehringer-Ingelheim Recent Development
Table 140. Indian Immunologicals Corporation Information
Table 141. Indian Immunologicals Description and Business Overview
Table 142. Indian Immunologicals DNA Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 143. Indian Immunologicals DNA Vaccines Product
Table 144. Indian Immunologicals Recent Development
Table 145. Plumbline Life Sciences Corporation Information
Table 146. Plumbline Life Sciences DNA Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 147. Plumbline Life Sciences Description and Business Overview
Table 148. Plumbline Life Sciences DNA Vaccines Product
Table 149. Plumbline Life Sciences Recent Development
Table 150. Production Base and Market Concentration Rate of Raw Material
Table 151. Key Suppliers of Raw Materials
Table 152. DNA Vaccines Distributors List
Table 153. DNA Vaccines Customers List
Table 154. DNA Vaccines Market Trends
Table 155. DNA Vaccines Market Drivers
Table 156. DNA Vaccines Market Challenges
Table 157. DNA Vaccines Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. DNA Vaccines Product Picture
Figure 2. Global DNA Vaccines Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global DNA Vaccines Sales Market Share by Application in 2021 & 2027
Figure 6. Human Examples
Figure 7. Animal Examples
Figure 8. Global DNA Vaccines Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global DNA Vaccines Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global DNA Vaccines Sales (K Doses) Growth Rate (2016-2027)
Figure 11. Global DNA Vaccines Price Trends Growth Rate (2016-2027) (USD/Dose)
Figure 12. Global DNA Vaccines Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global DNA Vaccines Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America DNA Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America DNA Vaccines Sales (K Doses) Growth Rate (2016-2027)
Figure 16. Europe DNA Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe DNA Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China DNA Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China DNA Vaccines Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan DNA Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan DNA Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia DNA Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia DNA Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India DNA Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India DNA Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest DNA Vaccines Players Market Share by Revenue in DNA Vaccines: 2016 & 2020
Figure 27. DNA Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global DNA Vaccines Revenue Share by Type (2016-2021)
Figure 29. Global DNA Vaccines Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global DNA Vaccines Revenue Share by Application (2016-2021)
Figure 31. Global DNA Vaccines Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America DNA Vaccines Sales Market Share by Type in 2020
Figure 33. North America DNA Vaccines Sales Market Share by Application in 2020
Figure 34. Europe DNA Vaccines Sales Market Share by Type in 2020
Figure 35. Europe DNA Vaccines Sales Market Share by Application in 2020
Figure 36. China DNA Vaccines Sales Market Share by Type in 2020
Figure 37. China DNA Vaccines Sales Market Share by Application in 2020
Figure 38. Japan DNA Vaccines Sales Market Share by Type in 2020
Figure 39. Japan DNA Vaccines Sales Market Share by Application in 2020
Figure 40. Southeast Asia DNA Vaccines Sales Market Share by Type in 2020
Figure 41. Southeast Asia DNA Vaccines Sales Market Share by Application in 2020
Figure 42. India DNA Vaccines Sales Market Share by Type in 2020
Figure 43. India DNA Vaccines Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of DNA Vaccines
Figure 46. Manufacturing Process Analysis of DNA Vaccines
Figure 47. DNA Vaccines Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
世界のヒトDNAワクチン市場規模・現状・予測（2021年-2027年） DNA vaccines have evolved greatly over the last 20 years since their invention, but have yet to become a competitive alternative to conventional protein or carbohydrate based human vaccines. Whilst safety concerns were an initial barrier, the Achilles heel of DNA vaccines remains their poor immunoge…- 世界の遺伝子欠失ワクチン市場規模・現状・予測（2021年-2027年） A Gene Deletion Vaccine is a vaccine developed without the ability to replicate by deleting important genes.These substances are very harmless because they cannot be released into the environment.Another benefit of live vaccines is that they can often be delivered via the mucosal route, which is a n…
- ヒトDNAワクチンのグローバル市場：規模・現状・予測2019-2025 DNA vaccines have evolved greatly over the last 20 years since their invention, but have yet to become a competitive alternative to conventional protein or carbohydrate based human vaccines. Whilst safety concerns were an initial barrier, the Achilles heel of DNA vaccines remains their poor immunoge…
- ヒトDNAワクチンのグローバル市場：規模・現状・予測2019-2025 DNA vaccines have evolved greatly over the last 20 years since their invention, but have yet to become a competitive alternative to conventional protein or carbohydrate based human vaccines. Whilst safety concerns were an initial barrier, the Achilles heel of DNA vaccines remains their poor immunoge…
- ヒトDNAワクチンのグローバル市場：規模・現状・予測2019-2025 DNA vaccines have evolved greatly over the last 20 years since their invention, but have yet to become a competitive alternative to conventional protein or carbohydrate based human vaccines. Whilst safety concerns were an initial barrier, the Achilles heel of DNA vaccines remains their poor immunoge…